Literature DB >> 22065298

Developmental and persistent developmental stuttering: an overview for primary care physicians.

John V Ashurst1, Megan N Wasson.   

Abstract

Stuttering is a speech disorder characterized by a disruption in the fluency, timing, and rhythm of normal speech. It affects approximately 5% of children at some point in their lives. Although dysfluency often resolves before adulthood, it may cause periods of extreme anxiety for patients, especially those who continue to stutter in adolescence and adulthood. Although these patients are unlikely to stop stuttering, treatment options are available to reduce anxiety and therefore the severity of symptoms. In the present review article, the authors discuss the pathophysiology, diagnosis, and management of developmental stuttering in children and adults.

Entities:  

Mesh:

Year:  2011        PMID: 22065298

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  3 in total

1.  Risperidone: stuttering.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2014-03

2.  Neurofilament-lysosomal genetic intersections in the cortical network of stuttering.

Authors:  Claudia Benito-Aragón; Ricardo Gonzalez-Sarmiento; Thomas Liddell; Ibai Diez; Federico d'Oleire Uquillas; Laura Ortiz-Terán; Elisenda Bueichekú; Ho Ming Chow; Soo-Eun Chang; Jorge Sepulcre
Journal:  Prog Neurobiol       Date:  2019-10-24       Impact factor: 11.685

Review 3.  Drug-induced stuttering: A comprehensive literature review.

Authors:  Naemeh Nikvarz; Salehe Sabouri
Journal:  World J Psychiatry       Date:  2022-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.